Skip to main content
VREOF
OTC Life Sciences

Vireo Amends Planet 13 Merger to Add Illinois IDFPR License Approval Condition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$5.953
Mkt Cap
$348.114M
52W Low
$5.95
52W High
$21.762
52W Position info
0.1% above low
Off High info
73% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

VREOF is trading near its 52-week low of $5.95 (0.1% above the low).

Summary

Vireo amended its all-stock Planet 13 merger agreement to expressly condition closing on Illinois IDFPR approval of the change in ownership of Planet 13's Illinois dispensing license. Deal economics are unchanged; the Planet 13 shareholder vote remains set for December 10, 2026.


Key Events · M&A and Partnerships · VREOF

  • Merger Agreement Amended for Illinois Regulator

    On November 12, 2026, Vireo and Planet 13 signed a First Amendment to their July 26, 2026 merger agreement in response to a request from the Illinois Department of Financial and Professional Regulation.

  • Illinois License Approval Becomes Closing Condition

    Section 6.2(e) now expressly requires IDFPR approval of the change in ownership and control of Planet 13 Illinois LLC's Registered Adult Use Dispensing License No. 284.000162-AUDO, while Section 5.4(d) bars any license assignment that would contravene 410 ILCS 705/15-60(g).

  • Deal Economics Unchanged

    The Amendment does not otherwise modify the terms of the Merger Agreement; the all-stock exchange ratio and consideration are untouched.

  • Planet 13 Vote Set for December 10, 2026

    The definitive proxy statement/prospectus was declared effective November 2, 2026 and mailed to Planet 13 stockholders of record as of October 29, 2026 ahead of the December 10, 2026 special meeting.


Analysis · VREOF · Life Sciences

At the request of Illinois regulators, Vireo and Planet 13 signed a First Amendment to their July 26, 2026 merger agreement. The exchange ratio and economics are untouched; instead, the amendment rewrites the regulatory closing condition so the deal expressly requires IDFPR approval of the change in ownership and control of Planet 13's Illinois adult-use dispensing license, and it blocks any license assignment that would violate Illinois law. What was a vague regulatory condition is now a named, state-specific approval the deal cannot close without. With the Planet 13 shareholder vote set for December 10, 2026, the remaining gating item is clearly the Illinois sign-off rather than the shareholder ballot.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VREOF was trading at $5.95 on OTC in the Life Sciences sector, with a market capitalization of approximately $348.1M. The 52-week trading range was $5.95 to $21.76. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREOF - Latest Insights

VREOF
Nov 16, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.29
Real-time Price: $5.95 info
Change: -$0.336528 (-5%) info
Market Cap: $348.114M info
VREOF
Nov 12, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.76
Real-time Price: $5.95 info
Change: -$0.806528 (-12%) info
Market Cap: $348.114M info
VREOF
Nov 10, 2026, 4:05 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.68
Real-time Price: $5.95 info
Change: -$0.726528 (-11%) info
Market Cap: $348.114M info
VREOF
Nov 10, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.78
Real-time Price: $5.95 info
Change: -$0.826528 (-12%) info
Market Cap: $348.114M info
VREOF
Oct 30, 2026, 4:15 PM EDT
Filing Type: S-4/A
Importance Score:
7
Price at Filing: $7.35
Real-time Price: $5.95 info
Change: -$1.40 (-19%) info
Market Cap: $348.114M info